Pure Global AI
IRCT20190317043079N3Recruiting

The effect of mindfulness-based therapy in reducing depression, anxiety and improving sleep in breast cancer patients

The effectiveness of mindfulness-based therapy in reducing depression, anxiety and improving sleep in breast cancer patients
Babol University of Medical SciencesPhase 3Iranian Registry Of Clinical Trialdrug
VerifiedIranian Registry Of Clinical Trial
Study focus
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Babol University of Medical Sciences
Location
Iran
Timeline & enrollment
Phase
Phase 3
Start date
Jan 21, 2023
End date
N/A
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastMalignant neoplasm: Breast, unspecifiedMalignant neoplasm: Central portion of breastPersonal history of malignant neoplasm of breast
Data source
Registry
Iranian Registry Of Clinical Trial
Trial ID
IRCT20190317043079N3
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for IRCT20190317043079N3 through Pure Global AI's free database. This Phase 3 trial is sponsored by Babol University of Medical Sciences and is currently Recruiting. The study focuses on Malignant neoplasm of breast.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.